Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer

Contributed by: Business Wire

Logo

Tags

Science

Other Science

Biotechnology

Research

Pharmaceutical

Oncology

Health

Health Technology

Christoph Korpus

More Like This

Christoph Korpus, PhD, MBA, Chief Business Officer, Byondis

Byondis Appoints Christoph Korpus, PhD, MBA, as Chief Business Officer

Louis Denis, M.D., Chief Medical Officer, Byondis (Photo: Business Wire)

Byondis Appoints Louis Denis, M.D., as Chief Medical Officer

PR Newswire associated0

Bio X Cell Announces CEO Appointment

PR Newswire associated0

mAbxience Appoints Jurgen Van Broeck as New CEO

Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer

Louis Denis, MD, Chief Medical Officer, Byondis

Byondis Announces First Patient Dosed in Phase 1 Clinical Trial of Novel SIRPα-Directed Monoclonal Antibody BYON4228 in Patients With Advanced or Metastatic Solid Tumors

JB Agnus, Chief Business Officer, KBI Biopharma, Inc. (Photo: Business Wire)

KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

Hansa Biopharma appoints Dr Richard Philipson as Chief Medical Officer